275 related articles for article (PubMed ID: 17075491)
1. [Managing resistance to analogue antiviral drugs in a decompensated cirrhosis patient].
Zarski JP
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S20-1. PubMed ID: 17075491
[No Abstract] [Full Text] [Related]
2. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
Benhamou Y
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
[No Abstract] [Full Text] [Related]
3. Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis.
Tseng PL; Lu SN; Tung HD; Wang JH; Changchien CS; Lee CM
J Viral Hepat; 2005 Jul; 12(4):386-92. PubMed ID: 15985009
[TBL] [Abstract][Full Text] [Related]
4. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
Wiegand J; Tischendorf JJ; Nashan B; Klempnauer J; Flemming P; Niemann P; Rohde P; Manns MP; Trautwein C; Tillmann HL
Z Gastroenterol; 2004 Jan; 42(1):15-8. PubMed ID: 14997399
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
Taltavull TC; Chahri N; Verdura B; Gornals J; Lopez C; Casanova A; Cañas C; Figueras J; Casais LA
Transpl Int; 2005 Jul; 18(7):879-83. PubMed ID: 15948869
[TBL] [Abstract][Full Text] [Related]
6. [A case of liver cirrhosis B resistant to lamivudine showing the clinical effect of adefovir dipivoxil].
Sumida Y; Kanemasa K; Tachibana S; Maekawa K; Mori K; Minami M; Okanoue T
Nihon Shokakibyo Gakkai Zasshi; 2004 May; 101(5):521-4. PubMed ID: 15168763
[No Abstract] [Full Text] [Related]
7. [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].
Lin Q; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):722-5. PubMed ID: 19874684
[No Abstract] [Full Text] [Related]
8. Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants.
Liu CJ; Kao JH; Chen PJ; Chen TC; Lin FY; Lai MY; Chen DS
J Viral Hepat; 2006 Jun; 13(6):387-95. PubMed ID: 16842441
[TBL] [Abstract][Full Text] [Related]
9. Resistance to adefovir: a new challenge in the treatment of chronic hepatitis B.
Marcellin P; Asselah T
J Hepatol; 2005 Dec; 43(6):920-3. PubMed ID: 16246449
[No Abstract] [Full Text] [Related]
10. [Lamivudine and adefovir dipivoxil combination treatment for liver cirrhosis patients with CHB].
Yang DH; Xie SF; Wang YM; Zhao NF; Li MW
Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):473-4. PubMed ID: 18579006
[No Abstract] [Full Text] [Related]
11. [New antiviral agent. Hepatitis B therapy with slight resistance risk].
MMW Fortschr Med; 2003 Dec; 145(51-52):40. PubMed ID: 14974332
[No Abstract] [Full Text] [Related]
12. Adefovir for lamivudine resistant HBV: more than meets the eye.
Di Marco V; Craxì A
J Hepatol; 2007 Oct; 47(4):618-9; author reply 619-20. PubMed ID: 17697727
[No Abstract] [Full Text] [Related]
13. Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
Reijnders JG; Deterding K; Petersen J; Zoulim F; Santantonio T; Buti M; van Bömmel F; Hansen BE; Wedemeyer H; Janssen HL;
J Hepatol; 2010 Apr; 52(4):493-500. PubMed ID: 20185191
[TBL] [Abstract][Full Text] [Related]
14. Virological response and incidence of adefovir resistance in lamivudine-resistant patients treated with adefovir dipivoxil.
Chen CH; Wang JH; Lee CM; Hung CH; Hu TH; Wang JC; Lu SN; Changchien CS
Antivir Ther; 2006; 11(6):771-8. PubMed ID: 17310821
[TBL] [Abstract][Full Text] [Related]
15. Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?
Aloman C; Wands JR
Hepatology; 2003 Dec; 38(6):1584-7. PubMed ID: 14655682
[No Abstract] [Full Text] [Related]
16. Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.
Mutimer D
J Hepatol; 2005 Aug; 43(2):200-2. PubMed ID: 15975684
[No Abstract] [Full Text] [Related]
17. [The clinical study of adding on adefovir dipivoxil to treat for lamivudine resistant patients with chronic hepatitis B].
DING JG; SUN QF; FU RQ; WU YH; HONG L
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):387-8. PubMed ID: 19497209
[No Abstract] [Full Text] [Related]
18. Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.
Manolakopoulos S; Bethanis S; Koutsounas S; Goulis J; Vlachogiannakos J; Christias E; Saveriadis A; Pavlidis C; Triantos C; Christidou A; Papatheodoridis G; Karamanolis D; Tzourmakliotis D
Aliment Pharmacol Ther; 2008 Feb; 27(3):266-73. PubMed ID: 17988233
[TBL] [Abstract][Full Text] [Related]
19. [Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Marcellin P; Lada O
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S5-8. PubMed ID: 17075487
[No Abstract] [Full Text] [Related]
20. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
Bronowicki JP; Barraud H; Couzigou P
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490
[No Abstract] [Full Text] [Related]
[Next] [New Search]